Key Takeaways
The U.S. Food and Drug Administration is reviewing bemotrizinol, a sunscreen ingredient used widely overseas
The ingredient protects against both UVA and UVB rays
Public comments are open before a final decision is made
FRIDAY, Dec. 12, 2025 (HealthDay News) — Americans may soon have access to a new sunscreen ingredient already used around the world.
The U.S. Food and Drug Administration (FDA) announced Dec. 11 that it is reviewing a proposal to allow bemotrizinol in sunscreens sold in the United States.
The ingredient is already approved and widely used in Europe, Australia and parts of Asia.
Bemotrizinol offers broad protection against both UVA and UVB rays, which are known to damage skin and raise cancer risk. The ingredient "has low levels of absorption through t

TownTimes news.com

WISC-TV Channel 3000
NBC Southern California
USA TODAY National
ABC News
Associated Press US News
Cover Media
Raw Story
Reuters US Top
Columbia Daily Tribune
The Atlantic
The Hill